Friday, July 24, 2020 8:50:26 PM
at the offering in the low $30s and the stock went to the 70s and was a biotech stock.
In this case they go in for a steal even though maybe locked up for the ride for a little while
the potential here is immense.
The uplis
the results from the P3 will set the stage for the rocket launch
But the
ir combo with approved and soon to be approved Cart T drugs to smdampen the bad side affects in solid tumors and other indications could set the platform for these
drugs to be more tolerable and wffective
I see that Durant is playing his cards close to the vest and very methodicalhe has not yet shown his aces.When he does Gilead and JNJ will be
bidding Surants hand up and up.
I hope all HGEN longs enjoy the ride and not be discouraged by the temporary dips because results are on the way!
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM